365 related articles for article (PubMed ID: 8402733)
1. Antitumor response to recombinant murine interferon gamma correlates with enhanced immune function of organ-associated, but not recirculating cytolytic T lymphocytes and macrophages.
Black PL; Phillips H; Tribble HR; Pennington R; Schneider M; Talmadge JE
Cancer Immunol Immunother; 1993 Oct; 37(5):299-306. PubMed ID: 8402733
[TBL] [Abstract][Full Text] [Related]
2. Correlation of immunomodulatory and therapeutic activities of interferon and interferon inducers in metastatic disease.
Black PL; Phillips H; Tribble HR; Pennington R; Schneider M; Talmadge JE
J Cell Biochem; 1988 Apr; 36(4):377-92. PubMed ID: 3132467
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
Parhar RS; Lala PK
J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice.
Talmadge JE; Tribble HR; Pennington RW; Phillips H; Wiltrout RH
Cancer Res; 1987 May; 47(10):2563-70. PubMed ID: 3105865
[TBL] [Abstract][Full Text] [Related]
5. Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma.
Scher RL; Carras A; Schwab D; Richtsmeier WJ; Koch WM
Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1271-5. PubMed ID: 7576474
[TBL] [Abstract][Full Text] [Related]
6. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
Reed SG
J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
[TBL] [Abstract][Full Text] [Related]
7. Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon gamma plus tumor necrosis factor alpha.
Young MR; McCloskey G; Wright MA; Pak AS
Cancer Immunol Immunother; 1994 Jan; 38(1):9-15. PubMed ID: 8299123
[TBL] [Abstract][Full Text] [Related]
8. The effect of interferon-gamma treatment of rat tumour cells on their susceptibility to natural killer cell, macrophage and cytotoxic T-cell killing.
Yeoman H; Robins RA
Immunology; 1988 Feb; 63(2):291-7. PubMed ID: 2965096
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2-mediated suppression of murine lymphokine-activated killer cell activity generated from tumor-bearing hosts by interferon-gamma.
Nakajima I; Chu TM
Mol Biother; 1990 Dec; 2(4):228-32. PubMed ID: 2126942
[TBL] [Abstract][Full Text] [Related]
10. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
Mulé JJ; Yang J; Shu S; Rosenberg SA
J Immunol; 1986 May; 136(10):3899-909. PubMed ID: 2871106
[TBL] [Abstract][Full Text] [Related]
11. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice.
Li Q; Nakadai A; Takeda K; Kawada T
Toxicology; 2004 Nov; 204(1):41-50. PubMed ID: 15369847
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of combination of murine recombinant interferon beta, murine recombinant interferon gamma and human recombinant interleukin-2 in MethA-bearing mice.
Itoh T; Sakata Y; Yoshida Y; Tsushima K; Suzuki H; Saitoh S; Tamura Y; Ogasawara H; Sugimoto N; Takemori H
Cancer Immunol Immunother; 1990; 32(2):88-94. PubMed ID: 2126986
[TBL] [Abstract][Full Text] [Related]
13. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
14. Effects of recombinant interferon-gamma and interleukin-2 on the generation of lymphokine-activated killer cells in vitro.
Findley HW; Nasr S; Afify Z; Hnath R; Waldrep K; Ragab AH
Cancer Invest; 1990; 8(5):493-500. PubMed ID: 2124946
[TBL] [Abstract][Full Text] [Related]
15. Organophosphorus pesticides markedly inhibit the activities of natural killer, cytotoxic T lymphocyte and lymphokine-activated killer: a proposed inhibiting mechanism via granzyme inhibition.
Li Q; Nagahara N; Takahashi H; Takeda K; Okumura K; Minami M
Toxicology; 2002 Apr; 172(3):181-90. PubMed ID: 11893417
[TBL] [Abstract][Full Text] [Related]
16. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
17. Activity inhibition of cytolytic lymphocytes by omeprazole.
Scaringi L; Cornacchione P; Fettucciari K; Rosati E; Rossi R; Marconi P; Capodicasa E
Scand J Immunol; 1996 Sep; 44(3):204-14. PubMed ID: 8795713
[TBL] [Abstract][Full Text] [Related]
18. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo.
Gately MK; Warrier RR; Honasoge S; Carvajal DM; Faherty DA; Connaughton SE; Anderson TD; Sarmiento U; Hubbard BR; Murphy M
Int Immunol; 1994 Jan; 6(1):157-67. PubMed ID: 7908534
[TBL] [Abstract][Full Text] [Related]
19. Ablation of NK cell function during tumor growth favors Type 2-associated macrophages, leading to suppressed CTL generation.
Geldhof AB; van Ginderachter JA; Liu Y; Noël W; de Baetselier P
Clin Dev Immunol; 2003; 10(2-4):71-81. PubMed ID: 14768937
[TBL] [Abstract][Full Text] [Related]
20. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]